脂肪肝临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 脂肪肝（国际通用名 metabolic dysfunction-associated steatohepatitis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖MASH、NASH、非酒精性脂肪肝等说法。

正在招募的脂肪肝新药试验

• The Development of MASLD Among Survivors of Breast or Colorectal Cancer

  不适用招募中SwitzerlandNCT07280143

• A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

  I 期 / II 期招募中美国英国NCT06836609

• A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  III 期招募中美国Argentina澳大利亚BrazilNCT06528314

• A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)

  II 期招募中美国加拿大NCT07325526

• Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

  不适用招募中美国NCT06138821

• Digital Early Warning System for Acute Lung Injury in Liver Surgery

  不适用招募中中国NCT07070362

• A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

  III 期招募中美国澳大利亚加拿大中国香港NCT07221227

• A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  III 期招募中美国Argentina澳大利亚BelgiumNCT06419374

• Rezdiffra Pregnancy and Lactation Registry

  不适用招募中美国NCT07541469

• Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)

  不适用招募中Turkey (Türkiye)NCT07737340

• A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

  II 期招募中中国NCT07145151

• Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

  不适用招募中中国NCT07083336